Correlation of Gene Abnormalities and Clinical Manifestations of Aniridia
| Status: | Completed |
|---|---|
| Conditions: | Ocular |
| Therapuetic Areas: | Ophthalmology |
| Healthy: | No |
| Age Range: | 4 - Any |
| Updated: | 4/21/2016 |
| Start Date: | December 2005 |
| End Date: | October 2008 |
Phenotype-Genotype Correlation in Aniridia
This study will examine specific gene changes in patients with aniridia, a disease in which
the iris (colored part of the eye) is absent or partially absent, and will correlate the
changes with clinical manifestations of the disease. In aniridia, the eye often appears to
have no color, but only a larger than normal pupil. Patients may have impaired vision and
cataracts, glaucoma, nystagmus (rapid, involuntary eye movements), photophobia (light
sensitivity), displaced lens, underdeveloped retina, and thickened cornea. This study will
focus particularly on corneal changes.
Patients 4 years old and older with aniridia may be eligible for this study. Candidates are
screened with a family history and complete eye examination, including the following:
- Visual acuity testing using a vision chart.
- Eye pressure measurement.
- Fundus photography to examine the back of the eye: The pupils are dilated and special
photographs of the inside of the eye are taken to evaluate the retina and measure
changes that may occur over time. The camera flashes a bright light into the eye for
each picture.
- Slit lamp examination: Evaluation of the front part of the eye with a special
microscope called a slit lamp biomicroscope.
- Corneal thickness measurement.
Participants have blood drawn for genetic testing related to aniridia. Relevant medical
information, including disease severity and complications, is obtained over time. Family
members may also be requested to provide blood samples for genetic testing.
the iris (colored part of the eye) is absent or partially absent, and will correlate the
changes with clinical manifestations of the disease. In aniridia, the eye often appears to
have no color, but only a larger than normal pupil. Patients may have impaired vision and
cataracts, glaucoma, nystagmus (rapid, involuntary eye movements), photophobia (light
sensitivity), displaced lens, underdeveloped retina, and thickened cornea. This study will
focus particularly on corneal changes.
Patients 4 years old and older with aniridia may be eligible for this study. Candidates are
screened with a family history and complete eye examination, including the following:
- Visual acuity testing using a vision chart.
- Eye pressure measurement.
- Fundus photography to examine the back of the eye: The pupils are dilated and special
photographs of the inside of the eye are taken to evaluate the retina and measure
changes that may occur over time. The camera flashes a bright light into the eye for
each picture.
- Slit lamp examination: Evaluation of the front part of the eye with a special
microscope called a slit lamp biomicroscope.
- Corneal thickness measurement.
Participants have blood drawn for genetic testing related to aniridia. Relevant medical
information, including disease severity and complications, is obtained over time. Family
members may also be requested to provide blood samples for genetic testing.
This project, Phenotype-Genotype Correlation in aniridia, will study the specific mutations
in patients with aniridia and attempt to make a phenotype-genotype correlation.
Specifically, the study will determine whether specific mutations are more prevalent in
aniridic patients who have a predominant involvement of the corneal epithelium. A blood
sample will be collected from each individual for isolation of DNA and the PAX6 gene will be
sequenced and analyzed. The principal investigator is Brian Brooks and the associated
investigators are James Fielding Hejtmancik at the OMGS/OGVFB/NEI and Chi-Chao Chan, LI/NEI.
Associate Investigators at collaborating institutions include Edward Holland (University of
Cincinnati) and Ali Djalilian (University of Illinois, Chicago).
in patients with aniridia and attempt to make a phenotype-genotype correlation.
Specifically, the study will determine whether specific mutations are more prevalent in
aniridic patients who have a predominant involvement of the corneal epithelium. A blood
sample will be collected from each individual for isolation of DNA and the PAX6 gene will be
sequenced and analyzed. The principal investigator is Brian Brooks and the associated
investigators are James Fielding Hejtmancik at the OMGS/OGVFB/NEI and Chi-Chao Chan, LI/NEI.
Associate Investigators at collaborating institutions include Edward Holland (University of
Cincinnati) and Ali Djalilian (University of Illinois, Chicago).
- Patients that meet diagnostic criteria for aniridia will be recruited from the NEI
and Collaborating clinics. While diagnosis of aniridia is not expected to create
significant difficulty, every attempt will be made to document the clinical status of
each family member included in the study, and to document the clinical syndrome in at
least one affected individual by slit lamp photography. A total of 100 subjects will
be recruited for this study. There are no specific exclusion criteria other than
young age (less than 4 years old) which may pose difficulty in obtaining blood.
We found this trial at
3
sites
University of Cincinnati The University of Cincinnati offers students a balance of educational excellence and...
Click here to add this to my saved trials
University of Chicago One of the world's premier academic and research institutions, the University of...
Click here to add this to my saved trials
9000 Rockville Pike
Bethesda, Maryland 20892
Bethesda, Maryland 20892
Click here to add this to my saved trials